Résultats de recherche
Il y a 3 jours · Get a real-time ICON PLC (ICLR) stock price quote with breaking news, financials, statistics, charts and more.
Il y a 1 jour · On Monday, Baird has increased the price target for ICON plc (NASDAQ:ICLR) shares, moving the goalpost to $376 from the previous $367. The firm continues to endorse an Outperform rating for the global provider of outsourced development services to the pharmaceutical, biotechnology, and medical device industries.
Il y a 3 jours · The average price target for ICON PLC is $345.30, which is 7.65% higher than the current price. The consensus rating is "Strong Buy".
27 juin 2024 · Growth. Profitability. Momentum. Peers. Options. Charting. A high-level overview of ICON Public Limited Company (ICLR) stock. Stay up to date on the latest stock price, chart, news, analysis,...
Il y a 5 jours · Research ICON's (Nasdaq:ICLR) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more.
Il y a 3 jours · Analyst Recommendations on ICON Public Limited Company. Baird Adjusts Price Target on ICON to $367 From $363, Maintains Outperform Rating. May. 31. MT. UBS Adjusts ICON Price Target to $380 From $368, Maintains Buy Rating. Apr. 26. MT. Evercore ISI Adjusts Price Target on ICON to $350 From $325, Keeps Outperform Rating. Feb. 23.
Il y a 3 jours · ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations.
